Oncology
5,185 studies511 in 7 days2,486 in 30 days
Filters
Latest
5,185 studies
- Living beyond treatment: late effects and everyday life in Faroese breast cancer survivors
- The role of interleukins and immunological parameters in patients with colon cancer: an optical insight.
- Outcomes of non-metastatic HER-2 positive breast cancer before and after the introduction of anti-HER-2 therapy: a retrospective study from a tertiary Egyptian center.
- Composite Inflammatory Score for Predicting Progression-Free Survival in Metastatic Clear Cell Renal Cell Carcinoma Treated With First-Line Toripalimab Plus Axitinib.
- Impact of remote management using patient-reported outcomes on pain and anxiety after breast biopsy: the BIO-PSY randomized controlled trial.
- Rilvegostomig Plus Trastuzumab-Deruxtecan for Early-Stage Breast Cancer: The I-SPY2.2 Randomized Clinical Trial.
- Real-world comparative outcomes of first-line immune combinations (ICI-ICI vs ICI-TKI) in metastatic renal cell carcinoma with sarcomatoid features.
- CLDN18.2 in colorectal mucinous adenocarcinoma: a lineage-associated biomarker and emerging translational target
- Diagnostic Value of Combined Biomarkers and the Shock Index for Predicting Febrile Neutropenia and Clinical Outcomes in the Emergency Department: A Multivariate Regression Analysis
- Meeting Report of the 6th edition of metabolism and cancer symposium
- Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Pancreatic Neuroendocrine Neoplasms
- Venous Tumor Thrombus Across Malignancies: Imaging, Management, and Clinical Implications
- Monitoring of (Potentially Leukemia-Specific) Immune Cells After AML Relapse Post-Transplantation Across Treatment Groups and Disease Stages
- Clinical Artificial Intelligence in Non-Small Cell Lung Cancer: From Early Detection and Computational Pathology to Precision Oncology
- Beyond Event-Free Survival: A Multi-State Analysis of Local Recurrence, Metastasis, and Death in Soft Tissue Sarcoma
- Structure-Based Drug Discovery for Invasive Lobular Carcinoma: Druggable Targets and Translational Opportunities
- Associations between long-term exposure to ultraviolet radiation and site-specific cancer incidence: an ecological study in China between 2006 and 2016
- Dose- and time-resolved immune states in cervical cancer radiotherapy: dynamic multimodal biomarkers for adaptive immunoradiotherapy
- Astragaloside IV and tumor microenvironmental barriers: immune mechanisms, evidence hierarchy, and implications for checkpoint blockade
- Mechanism-resolving development of solid-tumor CAR T-cell therapy: linking programmable control to tissue pharmacodynamics
- Multi-omics of tertiary lymphoid structures in breast cancer: clinical significance and biomarker potential
- Hormonal and nutritional biomarkers in immune checkpoint inhibition for gastrointestinal cancers: a narrative review
- Immune checkpoint inhibitors combined with VEGF/VEGFR-targeted therapy in microsatellite-stable advanced colorectal cancer: clinical advances and the potential for immune-sensitive tumor conversion
- Molecular mechanisms by which the intratumoral microbiome drives pancreatic ductal adenocarcinoma progression and therapeutic response
- Immune remodeling of breast tumor-draining lymph nodes: antigen-presenting cell dysfunction, regulatory T-cell expansion, and premetastatic niche formation